Behrman Capital Names Robert Byrnes Operating Partner; Leading Executive In Health Care Industry

May 11, 1998, 01:00 ET from Behrman Capital

    NEW YORK and SAN FRANCISCO, May 11 /PRNewswire/ -- Behrman Capital, a
 private investment firm focusing on emerging growth companies, today announced
 that Robert F. Byrnes has joined the firm as an operating partner.
     Mr. Byrnes, 53, has had a distinguished career as a health care executive
 in start-up, mid-size, and Fortune 100 companies covering a wide spectrum of
 the health care industry. As an operating partner at Behrman Capital, Mr.
 Byrnes will be involved in finding and evaluating potential acquisition
 candidates and developing new platforms in the health care services sector for
 the firm's continued expansion.  He will also work with existing portfolio
 companies to add value and will act as a non-executive chairman or board
 member for new portfolio companies.
     "We are very pleased that someone of Bob Byrnes' outstanding experience
 and proven ability is joining our team," said Darryl G. Behrman, a Managing
 Partner of Behrman Capital.  "Bob has had an extremely successful and diverse
 career, serving as business executive, consultant, entrepreneur, turnaround,
 and merger expert for both private and public companies. In particular, his
 experience ranges from successfully managing specialty drug, device, and
 health care service operations, to raising private funding for four start-up
 companies, three of which went public. Bob's varied skills, as well as his
 broad and deep knowledge of the health care industry and significant
 managerial experience, will be invaluable to us and our portfolio companies as
 we continue to grow our firm."
     In addition to his responsibilities at Behrman Capital, Mr. Byrnes will
 continue to serve as President and CEO of ROAN Inc., a consulting firm that
 provides strategic, operational and financial advisory services to small and
 medium size healthcare organizations.
     Prior to creating ROAN Inc. in 1997, Mr. Byrnes served as President and
 CEO of Matria Healthcare Inc., a specialty obstetrics and gynecological
 (OB/GYN) service organization.  He successfully oversaw the creation of Matria
 -- which was born out of the March, 1996 merger of Healthdyne, Inc and Tokos
 Medical Corporation.  Before merging Tokos with Healthdyne, Mr. Byrnes was
 Chairman and CEO of Tokos, which under his leadership grew from a start-up
 specialty OB/GYN device and service organization into the leading national
 provider of OB/GYN homecare services for high-risk, complicated pregnancies.
     Mr. Byrnes has also held senior management positions at Caremark, Inc., a
 start-up homecare company focusing on patients requiring infusion therapies
 and nutritional support;  Genentech, Inc., a start-up company which was the
 first to develop, manufacture, and market biotech pharmaceuticals; and
 American Hospital Supply Corporation, a multinational healthcare company.  He
 also worked for Abbot Laboratories, Eli Lilly and Co., and Osco Drugs during
 the early years of his career.
     Over the past sixteen years, Mr. Byrnes has had extensive board
 experience, serving as a member of fifteen different Boards of Directors for
 non-profit, public and private  organizations. He has a B.S. in Pharmacy from
 Ferris State University in Big Rapids, Michigan, and an M.B.A. from Loyola
 University in Chicago.
     Behrman Capital invests in management buyouts of growth companies focused
 on the health care services, outsourced manufacturing, and information
 technology industries, as well as special situations. The firm also provides
 expansion capital to emerging growth companies, principally in the high
 technology and health care services industries.
     Based in New York City and San Francisco, Behrman Capital was founded in
 1992 by Darryl G. and Grant G. Behrman. The firm currently has a combined
 capital base exceeding $640 million.

SOURCE Behrman Capital